CORDIS Project
Funding breakdown and partner intelligence are Premium
Sign in and upgrade to Premium for EU contribution totals, consortium analytics, OpenAlex research context, and AI summaries. · 0 consortium intelligence fields visible of 1
Start free • Cancel anytime • 14-day refund guarantee
This project aims to improve kidney transplant outcomes by using Torque Teno virus levels to guide immunosuppressive drug dosing. By personalizing treatment, it seeks to reduce infection and graft rejection rates, ultimately enhancing patient survival and lowering healthcare costs in Europe.
Challenge:
End stage renal disease (ESRD) causes high socioeconomic burden for citizens and the healthcare system in Europe.
Kidney transplantation represents the treatment standard for ESRD.
Graft rejection due to inadequate immunosuppression is the leading cause for chronic graft dysfunction and infectious disease due to reduced immune function is a major cause of death.
Optimisation of immunosuppressive drugs is a crucial step to minimize the risk of infection and rejection and thereby prolon…
Partner organizations (coordinator is shown above), with normalized type and CORDIS activity type. Guests see up to 4 partners.
France, Marcy-l'Etoile
Type: Company (for-profit)
Activity type: Private for-profit entities (excluding Higher or Secondary Education Establishments)
SME: No
Austria, Wien
Type: SME
Activity type: Private for-profit entities (excluding Higher or Secondary Education Establishments)
SME: Yes
Czechia, Brno
Type: University / higher education
Activity type: Higher or Secondary Education Establishments
SME: No
Similar projects, consortium collaboration history, frequent partners, and OpenAlex research context.
Guests see up to 5 EuroSciVoc fields.
Guests see up to 5 topics.
Guests see up to 5 keywords.
